3
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Oocyte donation in infertility treatment

A review

, &
Page 191 | Received 12 Jul 2000, Accepted 01 Nov 2000, Published online: 09 Sep 2009

References

  • Lutjen P, Trounson A, Leeton J, Findlay J, Wood C, Renou P The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 1984; 307: 174–5.
  • Söderström-Anttila V, Hovatta O. An oocyte donation program with goserelin down-regulation of voluntary donors. Acta Obstet Gynecol Scand 1995; 74: 288–92.
  • Aittomäki K, Lucena JLD, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotrophic ovarian failure. Cell 1995; 82: 959–68.
  • Anasti JN. Premature ovarian failure: an update. Fertil Steril 1998; 70: 1–15.
  • Conway G, Payne NN, Webb J, Murray A, Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 1998; 13: 1184–7.
  • Marozzi A, Vegetti W, Manfredini E, Tibiletti MG, Testa G, Crosignani PG et al. Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod 2000; 15: 197–202.
  • Navot D, Fox JH, Williams M, Brodman M, Friedman F, Cohen JC. The concept of uterine preservation with ovarian malignancies. Obstet Gynecol 1991; 78: 566–8.
  • Remohi J, Vidal A, Pellicer A. Oocyte donation in low responders to conventional ovarian stimulation for in vitro fertilization. Fertil Steril 1993; 59: 1208–15.
  • Ezra Y, Simon A, Laufer N. Defective oocytes: a new subgroup of unexplained infertility. Fertil Steril 1992; 58: 24–7.
  • Remohi J, Gallardo E, Levy M, Valbuena D, los Santos MJ, Simon C et al. Oocyte donation in women with recurrent pregnancy loss. Hum Reprod 1996; 11: 2048–51.
  • Van Voorhis BJ, Williamson RA, Gerard JL, Hammitt DG, Syrop CH. Use of oocytes from anonymous, matched, fertile donors for prevention of heritable genetic diseases. J Med Genet 1992; 29: 398–9.
  • Fridström M, Ährlund-Richter L, Rosenlund B, Sjöblom P, Ek I, Hillensjö T et al. Clinical outcome of treatment cycles with preimplantation genetic diagnosis in structural chromosomal abnormalities. (Submitted).
  • Antinori S, Versaci C, Hossein Gholami G, Panci C, Caffa B. Oocyte donation in menopausal women. Hum Reprod 1993; 8: 1487–90.
  • Sauer MV Paulson RJ, Lobo RA. Pregnancy after age 50. Application of oocyte donation to women after natural menopause. Lancet 1993; 341: 321–3.
  • Nagel TC, Tesch LG. ART and high risk patients. Fertil Steril 1997; 68: 748.
  • Foudila T, Söderström-Anttila V Hovatta O. Turner’s syndrome and pregnancies after oocyte donation. Hum Reprod 1999; 14: 532–5.
  • Ahuja KK, Simons EG, Edwards RG. Money, morals and medical risks: conflicting notions underlying the recruitment of egg donors. Hum Reprod 1999; 14: 279–84.
  • Ashkenazi J, Farhi J, Orvieto R, Homburg R, Dekel A, Feldberg D et al. Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient. Fertil Steril 1995; 64: 564–7.
  • Hazekamp JT. Current differences and consequences of legislation on practice of assisted reproductive technology in the Nordic countries. Acta Obstet Gynecol Scand 1996; 75: 198–200.
  • The American Fertility Society Guidelines for oocyte donation. Fertil Steril 1994; 64 (Suppl.): 105S–107S.
  • Barratt C, Englert Y, Gottlieb C, Jouannet P Gamete donation guidelines. The Corsendonk consensus document for the European Union. Hum Reprod 1998; 13: 500–1.
  • Frydman R, Cornel C, de Ziegler D, Taieb J, Spitz IM, Bouchard P. Spontaneous luteinizing hormone surges can be prevented by the timely administration of a gonadotrophin releasing hormone antagonist (Nal-Glu) during the late follicular phase. Hum Reprod 1992; 7: 930–3.
  • Navot D, Bergh PA, Williams M, Garrisi GJ, Guzman I, Sandler B et al. An insight into early reproductive processes through the in vivo model of ovum donation. J Clin Endocrinol Metab 1991; 72: 408–14.
  • Remohí J, Gutiérrez A, Cano F, Ruiz A, Simón C, Pellicer A. Long oestradiol replacement in an oocyte donation programme. Hum Reprod 1995; 10: 1387–91.
  • Borini A, Violini F, Bianchi L, Bafaro MG, Trevisi MR, Flamigni C. Improvement of pregnancy and implantation rates in cyclic women undergoing oocyte donation after long-term down-regulation. Hum Reprod 1995; 10: 3018–21.
  • Remohi J, Gallardo E, Duanes PP, Simon C, Pellicer A. Donor-recipient synchronization and the use of gonadotrophin-releasing hormone agonist to avoid the premature luteinizing hormone surge in oocyte donation. Hum Reprod 1995; 10 (suppl. 2): 84–90.
  • Bourgain C, Devroey P, Van Waesberghe L, Smitz J, Van Steirteghem AC. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum Reprod 1990; 5: 537–43.
  • Miles RA, Paulson RJ, Lobo RA, Press MF, Dahmoush L, Sauer MV. Pharmakokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: A comparative study. Fertil Steril 1994; 62: 485–90.
  • Paulson RJ, Hatch IE, Lobo RA, Sauer MV Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod 1997; 12: 835–9.
  • Remohi J, Gartner B, Gallardo E, Yalil S, Simon C, Pellicer A. Pregnancy and birth rates after oocyte donation. Fertil Steril 1997; 67: 717–23.
  • Serhal PF, Craft I. Oocyte donation in 61 patients. Lancet 1989; 2: 1185–7.
  • Gianaroli L, Bertocci F, Ferraretti AP, Mencaglia L. World survey of oocyte donation. Abstract. J Ass Reprod Genet 1997; 14 (suppl.): 32S.
  • Check JH, Nowroozi K, Chase J, Nazari A, Braithwaite C. Comparison of pregnancy rates following in vitro fertilization – embryo transfer between the donors and the recipients in a donor oocyte program. J Assist Reprod Genet 1992; 9: 248–50.
  • Abdalla HI, Billett A, Kan AKS, Baig S, Wren M, Korea L et al. Obstetric outcome in 232 ovum donation pregnancies. Br J Obstet Gynaecol 1998; 105: 332–7.
  • Edwards RG, Morcos S, Macnamee M, Balmaceda JP, Walters DE, Asch R. High fecundity of amenorrhoeic women in embryo-transfer programmes. Lancet 1991; 338: 292–4.
  • Söderström-Anttila V. Oocyte donation in the treatment of infertility. Helsinki: Tummavuoren kirjapaino, Vantaa, 1998.
  • Abdalla HI, Baber R, Kirkland A, Leonard T, Power M, Studd JWW. A report on 100 cycles of oocyte donation; factors affecting the outcome. Hum Reprod 1990; 5: 1018–22.
  • Pados G, Camus M, Van Waesberghe L, Liebaers I, Van Steirteghem A, Devroey P Oocyte and embryo donation: evaluation of 412 consecutive trials. Hum Reprod 1992; 7: 1111–17.
  • Press F, Shapiro HM, Cowell CA, Oliver GD. Outcome of ovum donation in Turner’s syndrome patients. Fertil Steril 1995; 64: 995–8.
  • Yaron Y, Ochshorn Y, Amit A, Yovel I, Kogosowski A, Lessing JB. Patients with Turner’s syndrome may have an inherent endometrial abnormality affecting receptivity in oocyte donation. Fertil Steril 1996; 65: 1249–52.
  • Sauer MV Paulson RJ, Lobo RA. Oocyte donation to women of advanced reproductive age: pregnancy results and obstetrical outcomes in patients 45 years and older. Hum Reprod 1996; 10: 2540–3.
  • Navot D, Drews MR, Bergh PA, Guzman I, Karstaedt A, Scott RT et al. Age-related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertil Steril 1994; 61: 97–101.
  • Pados G, Camus M, Van Steirteghem A, Bonduelle M, Devroey P The evolution and outcome of pregnancies from oocyte donation. Hum Reprod 1994; 9: 538–42.
  • Söderström-Anttila V, Tiitinen A, Foudila T, Hovatta O. Obstetric and perinatal outcome after oocyte donation – comparison with in vitro fertilization pregnancies. Hum Reprod 1998; 13: 483–90.
  • Salha O, Sharma V, Dada T, Nugent D, Rutherford AJ, Tomlinson AJ. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod 1999; 14: 2268–73.
  • Serhal PF, Craft IL. Immune basis for pre-eclampsia: evidence from oocyte recipients. Lancet 1987; 2: 744.
  • Hovatta O. Pregnancies in women with Turner’s syndrome. Ann Med 1999; 31: 106–10.
  • Bergh T, Ericson A, Hillensjö T, Nygren KG, Wennerholm UB. Deliveries and children born after in-vitro fertilisation in Sweden 1982–95: a retrospective cohort study. Lancet 1999; 6 (354 9190): 1579–85.
  • Söderström-Anttila V. Pregnancy and child outcome after oocyte donation. Hum Reprod Update 2000. In press.
  • Raoul-Duval A, Letur-Konirsch H, Frydman R. Anonymous oocyte donation: a psychological study of recipients, donors and children. Hum Reprod 1992; 7: 51–4.
  • Raoul-Duval A, Bertrand-Servais M, Letur-Konirsch H, Frydman R. Psychological follow-up of children born after in-vitro fertilization. Hum Reprod 1994; 9: 1097–101.
  • Applegarth L, Goldberg NC, Cholst I, McGoff N, Fantini D, Zellers N et al. Families created through ovum donation: A preliminary investigation of obstetrical outcome and psychosocial adjustment. J Assist Reprod Genet 1995; 12: 574–80.
  • Söderström-Anttila V, Sajaniemi N, Tiitinen A, Hovatta O. Health and development of children born after oocyte donation compared with that in those born after in vitro fertilization, and the parents’ attitudes regarding secrecy. Hum Reprod 1998; 13: 2009–15.
  • Golombok S, Murray S, Brinsden P, Abdalla H. Social versus biological parenting: family functioning and the socioemotional development of children conceived by egg or sperm donation. J Child Psychol Psychiatry 1999; 40: 519–27.
  • Jones HW Jr, Cohen J. IFFS surveillance 98. Fertil Steril 1999; 71 (suppl): 17S–18S.
  • Gunning J. Oocyte donation: the legislative framework in Western Europe. Hum Reprod suppl 1998; 13: 98–102.
  • Weil E, Cornet D, Sibony C, Mandelbaum J, Salat-Baroux J. Psychological aspects in anonymous and non-anonymous oocyte donation. Hum Reprod 1994; 9: 1344–7.
  • Munro J, Leeton J, Horsfall T. Psychosocial follow-up of families from a donor oocyte programme. Reprod Fertil Dev 1992; 4: 725–30.
  • Schover LR, Collins RL, Richards S. Psychological aspects of donor insemination: evaluation and follow-up of recipient couples. Fertil Steril 1992; 57: 583–90.
  • Brewaeys A, Golombok S, Naaktgeboren N, de Bruyn JK, van Hall EV Donor insemination: Dutch parents’ opinions about confidentiality and donor anonymity and the emotional adjustment of their children. Hum Reprod 1997; 12: 1591–7.
  • Schenker JG. Assisted reproduction practice in Europe: legal and ethical aspects. Hum Reprod Update 1997; 3: 173–84.
  • Gottlieb C, Lalos O, Lindblad F. Disclosure of donor insemination to the child: the impact of Swedish legislation on couples’ attitudes. Hum Reprod 2000; 15: 2052–6.
  • Kalfoglou AL, Gittelsohn J. A qualitative follow-up study of women’s experiences with oocyte donation. Hum Reprod 2000; 15: 798–805.
  • Cha KY, Chian RC. Maturation in vitro of immature human oocytes for clinical use. Human Reprod Update 1998; 4: 103–20.
  • Mikkelsen AL, Smith SD, Lindenberg S. In-vitro maturation of human oocytes from regularly menstruating women may be successful without follicle stimulating hormone priming. Hum Reprod 1999; 14: 1847–51.
  • Suikkari AM, Tulppala M, Tuuri T, Hovatta O, Barnes F. Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery, maturation and fertilization of immature human oocytes. Hum Reprod 2000; 15: 747–51.
  • Hovatta O, Silye R, Krausz T, Abir R, Margara R, Trew G et al. Cryopreservation of human ovarian tissue using dimethyl sulphoxide and propanediol-sucrose as cryoprotectants. Hum Reprod 1996; 11: 1268–72.
  • Newton H, Aubard Y, Rutherford A, Sharma V Gosden R. Low temperature storage and grafting of human ovarian tissue. Hum Reprod 1996; 11: 1487–91.
  • Parrott DMV The fertility of mice with orthotopic ovarian grafts derived from frozen tissue. J Reprod Fertil 1969; 1: 230–41.
  • Gosden RG, Baird DT, Wade JC, Webb R. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at —196°. Hum Reprod 1994; 9: 597–603.
  • Oktay K, Newton H, Gosden RG. Transplantation of cryopreserved human ovarian tissue results in follicle growth initiation in SCID mice. Fertil Steril 2000; 73(3): 599–603.
  • Yaron Y, Ochshorn Y, Amit A, Kogosowski A, Yovel I, Lessing JB. Oocyte donation in Israel: a study of 1001 initiated treatment cycles. Hum Reprod 1998; 13: 1819–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.